Department of Clinical Biochemistry, Herlev Gentofte Hospital, Copenhagen University Hospital, Borgmester Ib Juuls Vej 73, entrance 7, 4th floor N5, DK-2730 Herlev, Copenhagen, Denmark.
Copenhagen General Population Study, Herlev Gentofte Hospital, Copenhagen University Hospital, Herlev, Copenhagen, Denmark.
BMJ. 2020 Dec 8;371:m4266. doi: 10.1136/bmj.m4266.
To determine the association between levels of low density lipoprotein cholesterol (LDL-C) and all cause mortality, and the concentration of LDL-C associated with the lowest risk of all cause mortality in the general population.
Prospective cohort study.
Denmark; the Copenhagen General Population Study recruited in 2003-15 with a median follow-up of 9.4 years.
Individuals randomly selected from the national Danish Civil Registration System.
Baseline levels of LDL-C associated with risk of mortality were evaluated on a continuous scale (restricted cubic splines) and by a priori defined centile categories with Cox proportional hazards regression models. Main outcome was all cause mortality. Secondary outcomes were cause specific mortality (cardiovascular, cancer, and other mortality).
Among 108 243 individuals aged 20-100, 11 376 (10.5%) died during the study, at a median age of 81. The association between levels of LDL-C and the risk of all cause mortality was U shaped, with low and high levels associated with an increased risk of all cause mortality. Compared with individuals with concentrations of LDL-C of 3.4-3.9 mmol/L (132-154 mg/dL; 61st-80th centiles), the multivariable adjusted hazard ratio for all cause mortality was 1.25 (95% confidence interval 1.15 to 1.36) for individuals with LDL-C concentrations of less than 1.8 mmol/L (<70 mg/dL; 1st-5th centiles) and 1.15 (1.05 to 1.27) for LDL-C concentrations of more than 4.8 mmol/L (>189 mg/dL; 96th-100th centiles). The concentration of LDL-C associated with the lowest risk of all cause mortality was 3.6 mmol/L (140 mg/dL) in the overall population and in individuals not receiving lipid lowering treatment, compared with 2.3 mmol/L (89 mg/dL) in individuals receiving lipid lowering treatment. Similar results were seen in men and women, across age groups, and for cancer and other mortality, but not for cardiovascular mortality. Any increase in LDL-C levels was associated with an increased risk of myocardial infarction.
In the general population, low and high levels of LDL-C were associated with an increased risk of all cause mortality, and the lowest risk of all cause mortality was found at an LDL-C concentration of 3.6 mmol/L (140 mg/dL).
确定低密度脂蛋白胆固醇(LDL-C)水平与全因死亡率之间的关联,以及在普通人群中 LDL-C 浓度与全因死亡率最低风险相关的浓度。
前瞻性队列研究。
丹麦;哥本哈根普通人群研究于 2003-15 年招募,中位随访时间为 9.4 年。
从全国丹麦民事登记系统中随机选择的个体。
LDL-C 水平与死亡率风险相关的基线水平在连续尺度上(限制立方样条)和通过事先定义的百分位数类别进行评估,使用 Cox 比例风险回归模型。主要结局是全因死亡率。次要结局是特定原因死亡率(心血管疾病、癌症和其他死亡率)。
在 108243 名年龄在 20-100 岁的个体中,11376 人(10.5%)在研究期间死亡,中位年龄为 81 岁。LDL-C 水平与全因死亡率风险之间呈 U 型关系,低水平和高水平与全因死亡率风险增加相关。与 LDL-C 浓度为 3.4-3.9mmol/L(132-154mg/dL;第 61-80 百分位数)的个体相比,LDL-C 浓度<1.8mmol/L(<70mg/dL;第 1-5 百分位数)的个体全因死亡率的多变量调整风险比为 1.25(95%置信区间 1.15-1.36),LDL-C 浓度>4.8mmol/L(>189mg/dL;第 96-100 百分位数)的个体为 1.15(1.05-1.27)。在未接受降脂治疗的个体和整个人群中,与全因死亡率最低风险相关的 LDL-C 浓度为 3.6mmol/L(140mg/dL),而接受降脂治疗的个体为 2.3mmol/L(89mg/dL)。在男性和女性、各年龄段以及癌症和其他死亡率中,均观察到类似的结果,但在心血管死亡率中未观察到类似的结果。任何 LDL-C 水平的升高都与心肌梗死风险的增加相关。
在普通人群中,低水平和高水平的 LDL-C 与全因死亡率风险增加相关,而 LDL-C 浓度为 3.6mmol/L(140mg/dL)时全因死亡率最低。